• Inicio
  • Formações
  • Formação à Medida
  • News & Trends
  • Sobre nós
  • Contacto

EC MDR Guidance on New Safety and Clinical Performance Summary

The main purpose of this document is to provide guidance on the presentation,content and validation of the SSCP. The word “shall” is used when there is a corresponding “shall” in the MDR, otherwise “should” or “recommended” etc. is used indicating the interpretation of the MDR.

 

MDCG 2019-9 Summary of safety and clinical performance A guide for manufacturers and notified bodies

News & Trends

Procurar

Recentes

  • AI Act Complaints tool
  • EU MDR Update: New Harmonised Standards for Medical Devices
  • Clinical evidence for orphan in vitro diagnostic medical devices
  • Questions and answers for marketing authorisation holders/applicants referral on nitrosamine impurities in human medicinal products
  • TEAM NB Code of Conduct for Notified Bodies vs 5.3
  • GIRP POSITION PAPER: Revision of the EU Guidelines on Good Distribution Practice for Medicinal Products for Human Use
  • New guidance document MDCG 2026-6 on Guidance on clinical evidence for orphan IVDs
  • AI in pharmacovigilance – EMA update

91 257 00 03 (Chamada para a rede móvel nacional)
info@formiventos.com

  • Follow
  • CLIENTES & TESTIMONIALS
  • ASSOCIAÇÕES OFICIAIS
  • CERTIFICAÇÕES E CREDITAÇÕES
  • ADVISORY BOARD
  • Política de Privacidade
  • Contacto